The Rise of SARS-CoV-2 Variants and the Role of Convalescent Plasma Therapy for Management of Infections
Novel therapies for the treatment of COVID-19 are continuing to emerge as the SARSCov- 2 pandemic progresses. PCR remains the standard benchmark for initial diagnosis of COVID- 19 infection, while advances in immunological profiling are guiding clinical treatment. The SARSCov- 2 virus has undergo...
Saved in:
Main Author: | Keneth Iceland, Kasozi |
---|---|
Format: | Article |
Published: |
MDPI
2021
|
Subjects: | |
Online Access: | http://hdl.handle.net/20.500.12493/532 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Rise of SARS-CoV-2 Variants and the Role of Convalescent Plasma Therapy for Management of Infections
by: Mohamed, Moubarak, et al.
Published: (2023) -
Characterization of Vaccine-Enhanced Humoral Immune Responses Against Emergent SARS-CoV-2 Variants in a Convalescent Cohort
by: Jared Sheehan, et al.
Published: (2025-01-01) -
An Update on Anti-COVID-19 Vaccines and the Challenges to Protect Against New SARS-CoV-2 Variants
by: Fábio Mambelli, et al.
Published: (2025-01-01) -
Fc-binding nanodisc restores antiviral efficacy of antibodies with reduced neutralizing effects against evolving SARS-CoV-2 variants
by: Jaehyeon Hwang, et al.
Published: (2025-01-01) -
SARS-CoV-2 Evolution: Implications for Diagnosis, Treatment, Vaccine Effectiveness and Development
by: Fabrizio Angius, et al.
Published: (2024-12-01)